Jerri D Edwards1, Robert A Hauser, Melissa L O'Connor, Elise G Valdés, Theresa A Zesiewicz, Ergun Y Uc. 1. From the School of Aging Studies (J.D.E., E.G.V.) and Department of Neurology (R.A.H., T.A.Z.), University of South Florida, Tampa; Department of Human Development and Family Science (M.L.O.), North Dakota State University, Fargo; Department of Neurology (E.Y.U.), University of Iowa, Iowa City; and Neurology Service (E.Y.U.), Veterans Affairs Medical Center, Iowa City.
Abstract
OBJECTIVE: To examine the efficacy of cognitive speed of processing training (SOPT) among individuals with Parkinson disease (PD). Moderators of SOPT were also examined. METHODS:Eighty-seven adults, 40 years of age or older, with a diagnosis of idiopathic PD in Hoehn &; Yahr stages 1-3 and on a stable medication regimen were randomized to either 20 hours of self-administered SOPT (using InSight software) or a no-contact control condition. Participants were assessed at baseline and after 3 months of training (or an equivalent delay). The primary outcome measure was useful field of view test (UFOV) performance, and secondary outcomes included cognitive self-perceptions and depressive symptoms. RESULTS: Results indicated that participants randomized to SOPT experienced significantly greater improvements on UFOV performance relative to controls, Wilks λ = 0.938, F 1,72 = 4.79, p = 0.032, partial η(2) = 0.062. Findings indicated no significant effect of training on secondary outcomes, Wilks λ = 0.987, F2,70 < 1, p = 0.637, partial η(2) = 0.013. CONCLUSIONS:Patients with mild to moderate stage PD can self-administer SOPT and improve their cognitive speed of processing, as indexed by UFOV (a robust predictor of driving performance in aging and PD). Further research should establish if persons with PD experience longitudinal benefits of such training and if improvements translate to benefits in functional activities such as driving. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that SOPT improves UFOV performance among persons in the mild to moderate stages of PD.
RCT Entities:
OBJECTIVE: To examine the efficacy of cognitive speed of processing training (SOPT) among individuals with Parkinson disease (PD). Moderators of SOPT were also examined. METHODS: Eighty-seven adults, 40 years of age or older, with a diagnosis of idiopathic PD in Hoehn & Yahr stages 1-3 and on a stable medication regimen were randomized to either 20 hours of self-administered SOPT (using InSight software) or a no-contact control condition. Participants were assessed at baseline and after 3 months of training (or an equivalent delay). The primary outcome measure was useful field of view test (UFOV) performance, and secondary outcomes included cognitive self-perceptions and depressive symptoms. RESULTS: Results indicated that participants randomized to SOPT experienced significantly greater improvements on UFOV performance relative to controls, Wilks λ = 0.938, F 1,72 = 4.79, p = 0.032, partial η(2) = 0.062. Findings indicated no significant effect of training on secondary outcomes, Wilks λ = 0.987, F2,70 < 1, p = 0.637, partial η(2) = 0.013. CONCLUSIONS:Patients with mild to moderate stage PD can self-administer SOPT and improve their cognitive speed of processing, as indexed by UFOV (a robust predictor of driving performance in aging and PD). Further research should establish if persons with PD experience longitudinal benefits of such training and if improvements translate to benefits in functional activities such as driving. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that SOPT improves UFOV performance among persons in the mild to moderate stages of PD.
Authors: Karlene Ball; Daniel B Berch; Karin F Helmers; Jared B Jobe; Mary D Leveck; Michael Marsiske; John N Morris; George W Rebok; David M Smith; Sharon L Tennstedt; Frederick W Unverzagt; Sherry L Willis Journal: JAMA Date: 2002-11-13 Impact factor: 56.272
Authors: S Classen; D P McCarthy; O Shechtman; K D Awadzi; D N Lanford; M S Okun; R L Rodriguez; J Romrell; S Bridges; B Kluger; H H Fernandez Journal: Traffic Inj Prev Date: 2009-12 Impact factor: 1.491
Authors: Feng Lin; Kathi L Heffner; Ping Ren; Madalina E Tivarus; Judith Brasch; Ding-Geng Chen; Mark Mapstone; Anton P Porsteinsson; Duje Tadin Journal: J Am Geriatr Soc Date: 2016-06 Impact factor: 5.562
Authors: Jessica N Kraft; Hanna K Hausman; Cheshire Hardcastle; Alejandro Albizu; Andrew O'Shea; Nicole D Evangelista; Emanuel M Boutzoukas; Emily J Van Etten; Pradyumna K Bharadwaj; Hyun Song; Samantha G Smith; Steven DeKosky; Georg A Hishaw; Samuel Wu; Michael Marsiske; Ronald Cohen; Gene E Alexander; Eric Porges; Adam J Woods Journal: Geroscience Date: 2022-08-11 Impact factor: 7.581
Authors: Joseph DeGutis; Mallory Grosso; Thomas VanVleet; Michael Esterman; Laura Pistorino; Alice Cronin-Golomb Journal: Neurocase Date: 2015-09-11 Impact factor: 0.881
Authors: Kristin J Ford; Allen Joop; Raima A Memon; Kimberly H Wood; Karlene Ball; Gary R Cutter; David C Schwebel; Amy W Amara Journal: Mov Disord Date: 2017-10-04 Impact factor: 10.338
Authors: Aida Arroyo-Ferrer; Francisco José Sánchez-Cuesta; Yeray González-Zamorano; María Dolores Del Castillo; Carolina Sastre-Barrios; Marcos Ríos-Lago; Juan Pablo Romero Journal: Medicina (Kaunas) Date: 2021-03-26 Impact factor: 2.430
Authors: Ergun Y Uc; Kevin C Doerschug; Vincent Magnotta; Jeffrey D Dawson; Teri R Thomsen; Joel N Kline; Matthew Rizzo; Sara R Newman; Sonya Mehta; Thomas J Grabowski; Joel Bruss; Derek R Blanchette; Steven W Anderson; Michelle W Voss; Arthur F Kramer; Warren G Darling Journal: Neurology Date: 2014-07-02 Impact factor: 11.800